Oncology
News
Protein Expression Marker May Predict Response to Anthracyclines
Major Finding: Overexpression of TOP2A protein in breast cancer was found to be predictive of response to anthracyclines, independent of HER2 gene...
News
Axitinib Extends Progression-Free Survival in Kidney Cancer Trial
Major Finding: Patients treated with axitinib had a median progression-free survival of 6.7 months vs.
Commentary
Bending the Cost Curve: Hype and Hope
News
FDA Adds Warnings About High-Grade Prostate Cancer to BPH Drug Labels
News
New Cancer Patients Struggle to Get Appointments
Major Finding: Research assistants posing as patients with inoperable hepatocellular carcinoma got new-patient appointments only 23% of the time....
Conference Coverage
Video Report: Recession Impacts Cancer Screening, Treatment
News
Screen Breast Cancer Patients for Depression
Major Finding: Women whose depression scores improved during a 1-year treatment trial for metastatic breast cancer lived a median 53.6 months...
News
Positive Data on Alpharadin Could Accelerate Filing Timeline
News
Carboplatin Adds No Benefit to Standard Therapy for Basal-Like Breast Cancer
Major Finding: The pCR rate in basal-like breast cancer was 35% for standard chemotherapy with epirubicin, cyclophosphamide, and docetaxel, and 30...
Conference Coverage
Study: Flaxseed Bars Not Effective in Reducing Hot Flashes
Major Finding: Mean hot flash scores decreased by 4.9 units (about 33%) in the flaxseed arm, and by 3.5 (about 29%) in the placebo arm (P = .29)....
News
EBUS Equals Mediastinoscopy for NSCLC Staging
Major Finding: EBUS-TBNA proved similar to mediastinoscopy for lymph node staging of patients with operable NSCLC.